Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammasome components as new therapeutic targets in inflammatory disease
Rebecca C. Coll, Kate Schroder
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 23

Showing 23 citing articles:

The (neuro)inflammatory system in anxiety disorders and PTSD: Potential treatment targets
Anupam Sah, Nicolas Singewald
Pharmacology & Therapeutics (2025), pp. 108825-108825
Closed Access | Times Cited: 2
Degrading the key component of the inflammasome: Development of an NLRP3 PROTAC
Tim Keuler, Dominic Ferber, Jonas Engelhardt, et al.
Chemical Communications (2025)
Closed Access | Times Cited: 1
Role of inflammasomes in acute respiratory distress syndrome
Luke Flower, Emilio G. Vozza, Clare Bryant, et al.
Thorax (2025), pp. thorax-222596
Closed Access | Times Cited: 1
Tumor microenvironment regulation by reactive oxygen species-mediated inflammasome activation
Jeong‐Hoon Jang, Do-Hee Kim, Kyung‐Soo Chun
Archives of Pharmacal Research (2025)
Closed Access | Times Cited: 1
The Application of Selenium Nanoparticles in Immunotherapy
Yu Yang, Ying Liu, Qingxia Yang, et al.
Nano Biomedicine and Engineering (2024) Vol. 16, Iss. 3, pp. 345-356
Open Access | Times Cited: 5
Methyl Canthin-6-one-2-carboxylate Inhibits the Activation of the NLRP3 Inflammasome in Synovial Macrophages by Upregulating Nrf2 Expression
Yuanyuan Chen, Zongying Zhang, Yuan Yao, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 1, pp. 38-38
Open Access
ZBP1-driven cell death in severe influenza
David F. Boyd, Summer Vaughn Jordan, Siddharth Balachandran
Trends in Microbiology (2025)
Closed Access
Recent advances in nanomedicine therapy for bacterial pneumonia
Weiqian Jin, Ling Liao, Tao Qin, et al.
Chinese Chemical Letters (2025), pp. 110920-110920
Closed Access
Innate Immune Sensors and Cell Death—Frontiers Coordinating Homeostasis, Immunity, and Inflammation in Skin
Ye Mon Soe, Seen Ling Sim, Snehlata Kumari
Viruses (2025) Vol. 17, Iss. 2, pp. 241-241
Open Access
Selective and Potent Molecular Glue Degraders for NIMA‐related Kinase 7
Lu Chen, Lu Huang, Wuqiang Wen, et al.
Angewandte Chemie (2025)
Closed Access
Copper Oxide Nanoparticles Disrupt Lysosomal Function and Promote Foam Cell Formation in RAW264.7 Macrophages
Yilin Luo, Kun Zhang, Lejiao Mao, et al.
Toxicology (2025) Vol. 513, pp. 154101-154101
Closed Access
Recent insights and advances in gut microbiota's influence on host antiviral immunity
Ying Liu, Danying Yan, Ran Chen, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
New insights into the noncanonical inflammasome point to caspase-4 as a druggable target
Elad Elkayam, François G. Gervais, Hao Wu, et al.
Nature reviews. Immunology (2025)
Closed Access
Exogenous L-Serine Alleviates Pasteurella multocida-Induced Inflammation by Reprogramming the Transcription and Metabolism of Macrophages
Fang He, Zhengchun Lang, Yichao Huang, et al.
Veterinary Sciences (2025) Vol. 12, Iss. 3, pp. 254-254
Open Access
Liver injury in sepsis: manifestations, mechanisms and emerging therapeutic strategies
Xinqi Xu, Tingyu Yang, Jie An, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Novel Compounds as NLRP3 Inhibitors for Treating Asthma or COPD
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2025) Vol. 16, Iss. 4, pp. 538-539
Closed Access
When glycobiology meets inflammasome activation: Insights and implications
Hongliang Zhang, Tengchuan Jin, Mengzhou Xue, et al.
Journal of Advanced Research (2025)
Open Access
Mitochondrial dysfunction in AMI: mechanisms and therapeutic perspectives
Jingle Shi, Yiding Yu, Huajing Yuan, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Inflammasomopathies: mechanisms and disease signatures
Sara Cahill, Fiachra Humphries
Trends in Immunology (2025)
Closed Access
Genetic Regulation of Cell Death: Insights from Autoinflammatory Diseases
Hirotsugu Oda, Alessandro Annibaldi, Daniel L. Kastner, et al.
Annual Review of Immunology (2025) Vol. 43, Iss. 1, pp. 313-342
Closed Access
Novel Compounds as NLRP3 Inhibitors for Treating Asthma or COPD
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2025)
Closed Access
The NLRP3 inflammasome: A central player in multiple sclerosis
Almudena Otálora-Alcaraz, Thomas Reilly, Martí Oró-Nolla, et al.
Biochemical Pharmacology (2024), pp. 116667-116667
Closed Access | Times Cited: 1
IL-18 and IL-18BP: A Unique Dyad in Health and Disease
Daniela Novick
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13505-13505
Open Access | Times Cited: 1
Inflammasomes in neurodegenerative diseases
Qianchen Wang, Songwei Yang, Xuan Zhang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Alzheimers-associated inflammatory alterations mediate tau-associated neurodegeneration in limbic and temporal regions across clinical variants of Alzheimers disease
Patrick J. Lao, Seonjoo Lee, Daniel Talmasov, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top